The University of Chicago Header Logo

Connection

Larry Goldstein to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Larry Goldstein has written about Cost-Benefit Analysis.
Larry Goldstein
Connection Strength
0.132
Cost-Benefit Analysis
  1. Screening for asymptomatic carotid artery stenosis: caveat emptor. Ann Intern Med. 2014 Sep 02; 161(5):370-1.
    View in: PubMed
    Score: 0.099
  2. The Stroke P.O.R.T.: secondary and tertiary prevention of ischemic stroke. Stroke Prevention Patient Outcomes Research Team. Health Rep. 1994; 6(1):154-9.
    View in: PubMed
    Score: 0.024
  3. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl. 2000 Nov; 6(6):741-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.